Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11473 posts found.

Do doctors really use the Internet?

October 29, 2003 Sales and Marketing doctors, internet

Ever since the medical and pharmaceutical web emerged in the mid-90s, technology advocates have assumed that widespread use of the …
Feature

Celltech takes 10% stake in OGS

October 29, 2003 Sales and Marketing

News

Zyprexa approved for bipolar disorder

October 29, 2003 Sales and Marketing

Eli Lilly's market-leading schizophrenia drug Zyprexa has been granted European approval for the long-term treatment of bipolar disorder.The approval makes …
News

Shire cuts back ahead of US expansion

October 29, 2003 Sales and Marketing

Shire Pharmaceuticals is to revert to its original business model of marketing and developing specialist drugs in late stage clinical …
News

Pfizer/Pharmacia mega-merger gains final clearance

October 29, 2003 Sales and Marketing

The creation of a new pharmaceutical goliath is now just days away after Pfizer and Pharmacia received final regulatory clearance …
News

AstraZeneca prepares Crestor for battle

October 29, 2003 Sales and Marketing

AstraZeneca's US salesforce is gearing up to launch its potential blockbuster cholesterol-reducing drug Crestor, after receiving a long-awaited FDA approval.Crestor …
News

Yamanouchi reinforces US future with GSK deal

October 29, 2003 Sales and Marketing

Japanese pharma company Yamanouchi has struck a deal to co-market its forthcoming overactive bladder treatment with GlaxoSmithKline in the US. …
News

Exanta on NICE list ahead of marketing authorisation

October 29, 2003 Sales and Marketing

AstraZeneca's Exanta is to be in NICE's next programme of appraisals even though the blood-thinning drug has not yet received …
News

Aventis sues generic rivals over Lovenox

October 29, 2003 Sales and Marketing

Aventis has gone to court in the US to prevent generic versions of its second-biggest drug, blockbuster anti-thrombotic treatment Lovenox, …
News

BMJ puts industry relations under spotlight

October 29, 2003 Sales and Marketing

 Patients would benefit from less involvement between pharmaceutical companies and the medical profession, according to new research.A study of more …
News

Xeloda recommended for breast and colorectal cancer

October 29, 2003 Sales and Marketing

News

New SSRI inquiry to consider patient experiences

October 29, 2003 Sales and Marketing

The Government has conceded to intense pressure to give patients input into a new inquiry on the safety of SSRI …
News

Investors win battle of JP’s golden parachute

October 29, 2003 Sales and Marketing

News

Pele keeps playing for Pfizer

October 29, 2003 Sales and Marketing

Pele has signed up with Pfizer to continue his work on raising awareness of erectile dysfunction for the pharma company.The …
News

GSK international pharma chief leaves for Chiron

October 29, 2003 Sales and Marketing Chiron, David Stout, GSK, Howard Pien

 GlaxoSmithKline’s head of international pharmaceutical operations, Howard Pien, is to leave the company to become Chief Executive of Chiron.Mr Pien’s …
News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024